Developer docs
API playgroundTry for free, no card

Search company profiles

Fishawack

Full company profile

uuid000cfip

Namestring
Fishawack
Legal namestring
Avalere Health Topco Limited
Websiteurl
fishawack.com
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Fishawack, now operating under the Avalere Health brand, is a UK-based strategic healthcare partner serving global pharmaceutical, biotechnology, and life sciences companies. Founded in 2001 and headquartered in Knutsford with its operating entity (Avalere Health Topco Limited) registered in London at 66 City Road, the firm employs 501–1,000 people and maintains offices in the UK, US (Philadelphia and New York), and Japan. The company delivers three coordinated service lines—Advisory, Medical, and Marketing—structured around integrated cross-border strategic consulting, medical communications, and brand marketing for life sciences clients.

The firm's proprietary SenseMaking framework serves as its principal intellectual asset, integrating science, society, and systems into a unified strategic model for patient-centric engagements. Fishawack operates as a professional services organization rather than a technology platform: no app, API surface, SDK, or proprietary software is disclosed, revenue is generated through custom quote-based consulting and communications engagements, and public pricing is not available. Service value is produced through integrated content, medical education, and consulting deliverables rather than technology licensing.

Growth has been driven by a sustained acquisition and geographic expansion strategy. The firm executed at least twelve disclosed acquisitions between 2009 and 2019 across medical communications and life sciences services (including 2e Creative, Dudnyk, Blue Latitude Health, Carling Group, and Archimed Medical Communication). The 2024 entry into Japan—led by industry veteran Junji Yokokawa—and the contemporaneous launch of the Within Reach oncology anthology indicate continued geographic buildout and brand consolidation under the Avalere Health identity.

Short descriptiontext

Fishawack, operating as Avalere Health, is a UK-headquartered strategic healthcare partner serving global pharmaceutical and life sciences firms through integrated Advisory, Medical, and Marketing services, with offices in the UK, US, and Japan.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersKnutsford, United Kingdom
HQ citystring
Knutsford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting services, medical communications, healthcare marketing services, pharma advisory services, healthcare strategic consulting
Product category
Healthcare Consulting and Communications
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Within Reach
Description

An oncology anthology about what it really means to navigate cancer access, treatment, and care.

avalerehealth.com
Core offering1 text field

Fishawack (now operating as Avalere Health) provides fully-integrated, cross-border services to global pharmaceutical organisations. The company delivers Advisory, Medical, and Marketing service offerings to pharmaceutical, biotech, and life sciences clients, helping them navigate complex healthcare landscapes, communicate scientific data to healthcare professionals, and build patient-reaching brands. Its work is underpinned by a proprietary strategic framework called SenseMaking.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The company offers a unified Advisory, Medical, and Marketing service structure under a single mission. The three core service offerings—Advisory, Medical, and Marketing—operate in coordination, supported by the proprietary SenseMaking strategic model that powers their integrated approach to healthcare challenges.

Product and service3 records
1Advisory
CategoryStrategic advisory
2Medical
CategoryMedical communications
3Marketing
CategoryPharmaceutical marketing
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1IQVIA
TypeBroad incumbent
Description

IQVIA is the largest global pharma services and data company, with technology, real-world evidence, and consulting offerings that increasingly overlap with advisory and medical communications work for the same pharma clients.

2Publicis Health
TypeBroad incumbent
Description

Publicis Health is the dedicated health and pharma division of Publicis Groupe, offering creative, medical, and consulting services at greater scale — a key holding-company competitor for enterprise pharma accounts.

3Syneos Health
TypeBroad incumbent
Description

Syneos is a large clinical and commercial pharma services organization (now taken private) with significant medical communications and advisory capability — broader portfolio but overlapping in pharma strategy and comms engagements.

4EVERSANA
TypeDirect peer
Description

EVERSANA is a privately held, PE-backed integrated pharma services provider spanning commercial, medical affairs, and patient services — a comparable integrated-services challenger competing for similar pharma enterprise budgets.

5Real Chemistry
TypeDirect peer
Description

Real Chemistry is a large, PE-backed integrated healthcare communications and consulting firm combining data, creative, and medical communications — a closely comparable mid-sized, multi-capability peer.

6Omnicom Health Group
TypeBroad incumbent
Description

Omnicom Health Group is the largest dedicated healthcare agency network globally, bundling medical communications, advertising, and consulting — competing for the same enterprise pharma mandates at greater scale.

7Inizio
TypeDirect peer
Description

Inizio is a PE-backed (CD&R) global pharma services platform offering advisory, medical, and commercial services — almost a direct mirror of Fishawack/Avalere Health's three-pillar integrated model with similar M&A-driven growth.

8Klick Health
TypeDirect peer
Description

Klick is one of the largest independent health and pharma agencies in North America with deep medical, creative, and consulting capabilities, directly competing for global pharma communications mandates.

9WPP (Healthcare)
TypeBroad incumbent
Description

WPP's healthcare division (including VMLY&R Health, Ogilvy Health) is a large global network offering medical communications, advertising, and consulting services to pharma — competing for the same enterprise client roster.

10McCann Health
TypeBroad incumbent
Description

McCann Health is the global health and pharma network within IPG, offering medical communications, brand strategy, and consulting — a comparable network peer serving similar global pharma clients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A12 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fishawack

Healthcare Consulting and Communicationsfishawack.com

Fishawack, operating as Avalere Health, is a UK-headquartered strategic healthcare partner serving global pharmaceutical and life sciences firms through integrated Advisory, Medical, and Marketing services, with offices in the UK, US, and Japan.

What Fishawack does

Fishawack, now operating under the Avalere Health brand, is a UK-based strategic healthcare partner serving global pharmaceutical, biotechnology, and life sciences companies. Founded in 2001 and headquartered in Knutsford with its operating entity (Avalere Health Topco Limited) registered in London at 66 City Road, the firm employs 501–1,000 people and maintains offices in the UK, US (Philadelphia and New York), and Japan. The company delivers three coordinated service lines—Advisory, Medical, and Marketing—structured around integrated cross-border strategic consulting, medical communications, and brand marketing for life sciences clients.

The firm's proprietary SenseMaking framework serves as its principal intellectual asset, integrating science, society, and systems into a unified strategic model for patient-centric engagements. Fishawack operates as a professional services organization rather than a technology platform: no app, API surface, SDK, or proprietary software is disclosed, revenue is generated through custom quote-based consulting and communications engagements, and public pricing is not available. Service value is produced through integrated content, medical education, and consulting deliverables rather than technology licensing.

Growth has been driven by a sustained acquisition and geographic expansion strategy. The firm executed at least twelve disclosed acquisitions between 2009 and 2019 across medical communications and life sciences services (including 2e Creative, Dudnyk, Blue Latitude Health, Carling Group, and Archimed Medical Communication). The 2024 entry into Japan—led by industry veteran Junji Yokokawa—and the contemporaneous launch of the Within Reach oncology anthology indicate continued geographic buildout and brand consolidation under the Avalere Health identity.

Fishawack firmographics

Firmographics
Name
Fishawack
Legal name
Avalere Health Topco Limited
Website
https://fishawack.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Fishawack, operating as Avalere Health, is a UK-headquartered strategic healthcare partner serving global pharmaceutical and life sciences firms through integrated Advisory, Medical, and Marketing services, with offices in the UK, US, and Japan.
Ownership category
akta.pro rank

Where Fishawack is headquartered

Location

Headquarters

HQ city
Knutsford
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Fishawack business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels1 record

Marketing channels3 records

Fishawack product offering

Product offering

Core offering

Fishawack (now operating as Avalere Health) provides fully-integrated, cross-border services to global pharmaceutical organisations. The company delivers Advisory, Medical, and Marketing service offerings to pharmaceutical, biotech, and life sciences clients, helping them navigate complex healthcare landscapes, communicate scientific data to healthcare professionals, and build patient-reaching brands. Its work is underpinned by a proprietary strategic framework called SenseMaking.

Product overview

The company offers a unified Advisory, Medical, and Marketing service structure under a single mission. The three core service offerings—Advisory, Medical, and Marketing—operate in coordination, supported by the proprietary SenseMaking strategic model that powers their integrated approach to healthcare challenges.

Differentiator

Problem solved

Functional benefit

Brands

  • Within Reach: An oncology anthology about what it really means to navigate cancer access, treatment, and care.

Products and services

  • Advisory
  • Medical
  • Marketing

Companies that use Fishawack

Customer profile

Segments1 record

Ideal customer profiles1 record

Fishawack technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Fishawack partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

Fishawack competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest global pharma services and data company, with technology, real-world evidence, and consulting offerings that increasingly overlap with advisory and medical communications work for the same pharma clients.
  • Publicis Health: Publicis Health is the dedicated health and pharma division of Publicis Groupe, offering creative, medical, and consulting services at greater scale — a key holding-company competitor for enterprise pharma accounts.
  • Syneos Health: Syneos is a large clinical and commercial pharma services organization (now taken private) with significant medical communications and advisory capability — broader portfolio but overlapping in pharma strategy and comms engagements.
  • Omnicom Health Group: Omnicom Health Group is the largest dedicated healthcare agency network globally, bundling medical communications, advertising, and consulting — competing for the same enterprise pharma mandates at greater scale.
  • WPP (Healthcare): WPP's healthcare division (including VMLY&R Health, Ogilvy Health) is a large global network offering medical communications, advertising, and consulting services to pharma — competing for the same enterprise client roster.
  • McCann Health: McCann Health is the global health and pharma network within IPG, offering medical communications, brand strategy, and consulting — a comparable network peer serving similar global pharma clients.

Direct peers

  • EVERSANA: EVERSANA is a privately held, PE-backed integrated pharma services provider spanning commercial, medical affairs, and patient services — a comparable integrated-services challenger competing for similar pharma enterprise budgets.
  • Real Chemistry: Real Chemistry is a large, PE-backed integrated healthcare communications and consulting firm combining data, creative, and medical communications — a closely comparable mid-sized, multi-capability peer.
  • Inizio: Inizio is a PE-backed (CD&R) global pharma services platform offering advisory, medical, and commercial services — almost a direct mirror of Fishawack/Avalere Health's three-pillar integrated model with similar M&A-driven growth.
  • Klick Health: Klick is one of the largest independent health and pharma agencies in North America with deep medical, creative, and consulting capabilities, directly competing for global pharma communications mandates.

Market position

Strengths5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Fishawack social profiles

Digital presence

Fishawack financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fishawack leadership team

Management profile

Number of profiles

Profiles1 record

Fishawack funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fishawack M&A and investment

M&A and investment

M&A12 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fishawack

What does Fishawack do?

Fishawack (now operating as Avalere Health) provides fully-integrated, cross-border services to global pharmaceutical organisations. The company delivers Advisory, Medical, and Marketing service offerings to pharmaceutical, biotech, and life sciences clients, helping them navigate complex healthcare landscapes, communicate scientific data to healthcare professionals, and build patient-reaching brands. Its work is underpinned by a proprietary strategic framework called SenseMaking.

Is Fishawack a public or private company?

Fishawack is a private company. It is classified as unknown and is currently operating.

When was Fishawack founded?

Fishawack was founded in 2001. It employs 501 to 1,000 people.

Where is Fishawack based?

Fishawack is headquartered in Knutsford, United Kingdom, in the Europe region.

Who are Fishawack's main competitors?

Broad incumbents on record are IQVIA, Publicis Health, Syneos Health, Omnicom Health Group, WPP (Healthcare) and McCann Health. Direct peers are EVERSANA, Real Chemistry, Inizio and Klick Health.

Does Fishawack have an API?

No public API is recorded for Fishawack.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patientFishawack Health announced it is unifying under the new name Avalere Health, consolidating 19 best-in-class healthcare agencies and consultancies it acquired since its founding in 2001. The rebranded company, with over 1,500 experts across North America, Europe, and Asia-Pacific, positions itself as a global commercialization partner for the biopharmaceutical, medical technology, and wellness industries. The acquired brands including Hive, Pollen Health, Dudnyk, and others have been retired, while US-based Avalere—acquired in June 2022—will retain its brand as an integral part of the unified entity.PR NewswireIndustry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilitiesFishawack Health announced the appointment of Amar Urhekar as its new Chief Operating Officer, effective immediately, as part of an expansion of its executive leadership team. Urhekar, who previously served as Global Group President at Evoke and Global President at Ashfield Health, will oversee all FH services, unite the company's 1,600 employees across business units, and join the board of directors. He will focus on completing FH's integration strategy and building global cross-functional teams spanning North America, Europe, and Asia to accelerate growth and connect patients to therapies.PR NewswireFishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative OfficerFishawack Health announced organizational changes within its Marketing division, promoting Ryan Mason to Chief Marketing and Creative Officer and hiring Jeffrey D. Erb as Chief Media Officer to lead the newly integrated team. The restructuring aims to unify creative, brand strategy, and media and analytics capabilities under a single leadership structure to deliver connected customer experiences. Both executives will collaborate with other senior leaders to embed interdisciplinary expertise across client accounts and the company's 19 global hubs.PR NewswireStephen Galt, formerly of Fishawack Health, joins Cambridge Healthcare Research as Chief Commercial OfficerCambridge Healthcare Research (CHR) has appointed Stephen Galt as its new Chief Commercial Officer to drive the company's next phase of growth. Galt, formerly of Fishawack Health, will oversee revenue-generating activities across competitive intelligence, market research, and pricing. This executive hire is part of CHR's strategic initiative to enhance its commercial capabilities while maintaining operational rigour.PR NewswireFishawack Health appoints new CEO, Jonathan KochFishawack Health has appointed Jonathan Koch as its new Chief Executive Officer, succeeding Oliver Dennis who stepped down in September. Koch brings extensive experience from healthcare roles at Labcorp Drug Development and Henry Schein to lead the company's next phase of growth focused on team building and integrated services. This leadership change follows the appointment of Liz Landon as Chief People Officer, signaling a strategic shift for the commercialization partner.PR NewswireFishawack Health améliore son offre omnicanale grâce à l'acquisition de closerlook, une agence de marketing numérique axée sur l'analyseFishawack Health announced the acquisition of closerlook, a Chicago-based digital marketing agency specializing in data analytics and omnichannel solutions for the life sciences sector. This strategic move aims to integrate closerlook's artificial intelligence and data science capabilities with Fishawack's global commercialization services to enhance targeted marketing for pharmaceutical brands. The combination is designed to provide biopharmaceutical companies with advanced tools for optimizing patient and healthcare professional engagement throughout the drug lifecycle.PR NewswireFishawack Health dévoile une offre internationale inégalée d'accès au marché et de HEOR avec l'acquisition de PRMA ConsultingFishawack Health, a life sciences commercialization company, has acquired PRMA Consulting, a global market access and HEOR consulting firm, marking its third acquisition of 2021. The deal expands Fishawack Health's international capabilities by adding expertise across the Asia-Pacific, European, and US markets to complement its existing North American market access offerings. PRMA Consulting will integrate its suite of digital solutions, including PRMA Healthcheck, PRMA Navigator, PRMA Tracker, and PRMA Access Accelerator, into Fishawack Health's existing client portfolio.PR NewswireFishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA ConsultingLeading life science commercialization partner Fishawack Health has acquired PRMA Consulting, a premier global market access and health economics outcomes research consultancy, in what the company describes as its third acquisition of 2021. The deal adds deep expertise in Asia-Pacific and European markets to complement Fishawack Health's existing North American market access offering, creating one of the industry's leading combined capabilities. Fishawack Health intends to make PRMA Consulting's suite of digital applications—including PRMA Healthcheck, PRMA Navigator, PRMA Tracker, and PRMA Access Accelerator—available to all existing clients.PMLiVEFishawack Health adds The Hive Health Group to its networkFishawack Health acquired The Hive Health Group, a healthcare marketing and scientific communications agency with UK and US presence. The acquisition adds Hive Health and Pollen Health brands, expanding Fishawack's integrated offering in medical communications, consulting, and commercial services.PR NewswireFishawack Health se réorganise en tant qu'agence de commercialisation internationale dans un monde postpandémiqueFishawack Health, a UK-based healthcare communications company, announced the reorganization of its business operations into an international commercialization partner agency under a new unified identity, combining medical communications, commercial, and consulting capabilities. The restructuring responds to client demand for more integrated and flexible services, driven by complexity intensified by the COVID-19 pandemic, with the company having conducted extensive client research over two months to understand how clients are adapting to pandemic conditions. The company will publish findings from this research on October 31, 2020.